Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder.
Since 2012, studies in mice, rats, and humans have suggested that abnormalities in purinergic signaling may be a final common pathway for many genetic and environmental causes of autism spectrum disorder (ASD). The current study in mice was conducted to characterize the bioenergetic, metabolomic, br...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0248771&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850181686582575104 |
|---|---|
| author | Zarazuela Zolkipli-Cunningham Jane C Naviaux Tomohiro Nakayama Charlotte M Hirsch Jonathan M Monk Kefeng Li Lin Wang Thuy P Le Simone Meinardi Donald R Blake Robert K Naviaux |
| author_facet | Zarazuela Zolkipli-Cunningham Jane C Naviaux Tomohiro Nakayama Charlotte M Hirsch Jonathan M Monk Kefeng Li Lin Wang Thuy P Le Simone Meinardi Donald R Blake Robert K Naviaux |
| author_sort | Zarazuela Zolkipli-Cunningham |
| collection | DOAJ |
| description | Since 2012, studies in mice, rats, and humans have suggested that abnormalities in purinergic signaling may be a final common pathway for many genetic and environmental causes of autism spectrum disorder (ASD). The current study in mice was conducted to characterize the bioenergetic, metabolomic, breathomic, and behavioral features of acute hyperpurinergia triggered by systemic injection of the purinergic agonist and danger signal, extracellular ATP (eATP). Responses were studied in C57BL/6J mice in the maternal immune activation (MIA) model and controls. Basal metabolic rates and locomotor activity were measured in CLAMS cages. Plasma metabolomics measured 401 metabolites. Breathomics measured 98 volatile organic compounds. Intraperitoneal eATP dropped basal metabolic rate measured by whole body oxygen consumption by 74% ± 6% (mean ± SEM) and rectal temperature by 6.2˚ ± 0.3˚C in 30 minutes. Over 200 metabolites from 37 different biochemical pathways where changed. Breathomics showed an increase in exhaled carbon monoxide, dimethylsulfide, and isoprene. Metabolomics revealed an acute increase in lactate, citrate, purines, urea, dopamine, eicosanoids, microbiome metabolites, oxidized glutathione, thiamine, niacinamide, and pyridoxic acid, and decreased folate-methylation-1-carbon intermediates, amino acids, short and medium chain acyl-carnitines, phospholipids, ceramides, sphingomyelins, cholesterol, bile acids, and vitamin D similar to some children with ASD. MIA animals were hypersensitive to postnatal exposure to eATP or poly(IC), which produced a rebound increase in body temperature that lasted several weeks before returning to baseline. Acute hyperpurinergia produced metabolic and behavioral changes in mice. The behaviors and metabolic changes produced by ATP injection were associated with mitochondrial functional changes that were profound but reversible. |
| format | Article |
| id | doaj-art-dcd56786bb624e8fb59639e27974fd18 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-dcd56786bb624e8fb59639e27974fd182025-08-20T02:17:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01163e024877110.1371/journal.pone.0248771Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder.Zarazuela Zolkipli-CunninghamJane C NaviauxTomohiro NakayamaCharlotte M HirschJonathan M MonkKefeng LiLin WangThuy P LeSimone MeinardiDonald R BlakeRobert K NaviauxSince 2012, studies in mice, rats, and humans have suggested that abnormalities in purinergic signaling may be a final common pathway for many genetic and environmental causes of autism spectrum disorder (ASD). The current study in mice was conducted to characterize the bioenergetic, metabolomic, breathomic, and behavioral features of acute hyperpurinergia triggered by systemic injection of the purinergic agonist and danger signal, extracellular ATP (eATP). Responses were studied in C57BL/6J mice in the maternal immune activation (MIA) model and controls. Basal metabolic rates and locomotor activity were measured in CLAMS cages. Plasma metabolomics measured 401 metabolites. Breathomics measured 98 volatile organic compounds. Intraperitoneal eATP dropped basal metabolic rate measured by whole body oxygen consumption by 74% ± 6% (mean ± SEM) and rectal temperature by 6.2˚ ± 0.3˚C in 30 minutes. Over 200 metabolites from 37 different biochemical pathways where changed. Breathomics showed an increase in exhaled carbon monoxide, dimethylsulfide, and isoprene. Metabolomics revealed an acute increase in lactate, citrate, purines, urea, dopamine, eicosanoids, microbiome metabolites, oxidized glutathione, thiamine, niacinamide, and pyridoxic acid, and decreased folate-methylation-1-carbon intermediates, amino acids, short and medium chain acyl-carnitines, phospholipids, ceramides, sphingomyelins, cholesterol, bile acids, and vitamin D similar to some children with ASD. MIA animals were hypersensitive to postnatal exposure to eATP or poly(IC), which produced a rebound increase in body temperature that lasted several weeks before returning to baseline. Acute hyperpurinergia produced metabolic and behavioral changes in mice. The behaviors and metabolic changes produced by ATP injection were associated with mitochondrial functional changes that were profound but reversible.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0248771&type=printable |
| spellingShingle | Zarazuela Zolkipli-Cunningham Jane C Naviaux Tomohiro Nakayama Charlotte M Hirsch Jonathan M Monk Kefeng Li Lin Wang Thuy P Le Simone Meinardi Donald R Blake Robert K Naviaux Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder. PLoS ONE |
| title | Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder. |
| title_full | Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder. |
| title_fullStr | Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder. |
| title_full_unstemmed | Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder. |
| title_short | Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder. |
| title_sort | metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0248771&type=printable |
| work_keys_str_mv | AT zarazuelazolkiplicunningham metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder AT janecnaviaux metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder AT tomohironakayama metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder AT charlottemhirsch metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder AT jonathanmmonk metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder AT kefengli metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder AT linwang metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder AT thuyple metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder AT simonemeinardi metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder AT donaldrblake metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder AT robertknaviaux metabolicandbehavioralfeaturesofacutehyperpurinergiaandthematernalimmuneactivationmousemodelofautismspectrumdisorder |